Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice

Virus Research

Volumn 121, Issue 1, 2006, Pages 65-73

  Zulueta, Aída ^a   Martín, Jorge ^a   Hermida, Lisset ^a   Alvarez, Mayling ^b   Valdés, Iris ^a   Prado, Irina ^b   Chinea, Glay ^a   Rosario, Delfina ^b   Guillén, Gerardo ^a   Guzmán, María G ^b  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Dengue; Domain B; Domain III; Envelope; P64k; Viral strain

Indexed keywords

DENGUE VACCINE; PD 18; PD 9; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS FUSION PROTEIN PD18; VIRUS FUSION PROTEIN PD9;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DRUG POTENCY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; VIRUS ENVELOPE; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL OUTER MEMBRANE PROTEINS; DENGUE; DENGUE VIRUS; FEMALE; IMMUNIZATION; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL VACCINES;

DENGUE VIRUS GROUP; ESCHERICHIA COLI;

EID: 33745899363     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.04.003     Document Type: Article

References (45)

1. Beasley D.W.C., and Barrett A.D.T. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 76 (2002) 13097-13100
2. Brown R., Jarvis K., and Hyland K. Protein measurement using bicinchoninic acid: elimination of interfering substances. Ann. Biochem. 180 (1989) 136-139
3. Bullock W.O., Fernández J.M., and Short J.M. A high efficiency plasmid transforming recA Escherichia coli strain with Beta-Galactosidase selection. Biotechniques 4 (1987) 376-378
4. Chen Y., Maguire T., and Marks R.M. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol. 70 (1996) 8765-8772
5. Chinea G., Padron G., Hooft R.W., Sander C., and Vriend G. The use of position-specific rotamers in model building by homology. Proteins 23 (1995) 415-421
6. Clarke D.H., and Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod borne virus. Am. J. Trop. Med. Hyg. 7 (1958) 561-573
7. Cologna R., and Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77 (2003) 3929-3938
8. Guillén G., Álvarez A., Silva R., Morera V., González S., Musacchio A., Besada V., Coizeau E., Caballero E., Nazabal C., Carmenate T., González L.J., Estrada R., Tambara Y., Padrón G., and Herrera L. Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitides. Biotechnol. Appl. Biochem. 27 (1998) 189-196
9. Hermida L., Rodríguez R., Lazo L., Bernardo L., Silva R., Zulueta A., López C., Martín J., Valdés I., Rosario D., Guillen G., and Guzmán M.G. A fragment of the envelope protein from Dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice. Biotechnol. Appl. Biochem. 39 (2004) 107-114
10. Hermida L., Rodríguez R., Lazo L., Silva R., Zulueta A., Chinea G., López C., Guzmán M.G., and Guillén G. A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice. J. Virol. Methods 115 (2004) 41-49
11. Hiramatsu K., Tadano M., Men R., and Lai C.J. Analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 224 (1996) 437-445
12. Holzmann H., Heinz F.X., Mandl C.W., Guirakhoo F., and Kunz C. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 64 (1990) 5156-5159
13. Holzmann H., Stiasny K., Ecker M., Kunz C., and Heinz F.X. Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J. Gen. Virol. 78 (1997) 31-37
14. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., and Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 78 (2004) 378-388
15. Hutchinson E.G., and Thornton J.M. A revised set of potentials for beta-turn formation in proteins. Protein Sci. 3 (1994) 2207-2216
16. Igarashi A. Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J. Gen. Virol. 40 (1978) 531-544
17. Jin L., Fendly B.M., and Wells J.A. High resolution functional analysis of antibody-antigen interactions. J. Mol. Biol. 226 (1992) 851-865
18. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., and Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002) 717-725
19. Lacks S., and Greenberg J.R. Complementary specificity of restriction endonucleases of Diplococcus pneumoniae with respect to DNA methylation. J. Mol. Biol. 114 (1977) 153-168
20. Laemmli U.K. Protein measurement using bicinchoninic acid: elimination of interfering substances. Nature 227 (1970) 680-685
21. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., Ramos C., and Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73 (1999) 4738-4747
22. Li L., Barrett A.D.T., and Beasley D.W.C. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 335 (2005) 99-105
23. Lin C.W., and Wu S.C. A functional determinant on Domain III of the Japanese Encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J. Virol. 77 (2003) 2600-2606
24. Ludolfs D., Schilling S., Altenschmidt J., and Schmitz H. Serological differentiation of infections with dengue virus Serotypes 1 to 4 by using recombinant antigens. J. Clin. Microb. 40 (2002) 4317-4320
25. Modis Y., Ogata S., Clements D., and Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79 (2005) 1223-1231
26. Monath T.P., and Heinz F.X. Flaviviruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology. third ed. (1996), Lippincott-Raven, Philadelphia, PA
27. Morens D.M., Halstead S.B., Repik P.M., Putvatana R., and Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22 (1985) 250-254
28. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., and Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437 (2005) 764-769
29. Pellequer J.L., Westhof E., and Van Regenmortel M.H. Correlation between the location of antigenic sites and the prediction of turns in proteins. Immunol. Lett. 36 (1993) 83-99
30. Pérez A., Dickinson F., Cinza Z., Ruiz A., Serrano T., Sosa J., González S., Gutiérrez Y., Nazábal C., Gutiérrez O., Guzmán D., Díaz M., Delgado M., Caballero E., Sardiñas G., Álvarez A., Martín A., Guillén G., and Silva R. Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers. Biotechnol. Appl. Biochem. 34 (2001) 121-125
31. Rey F.A., Heinz F.X., Mandl C.W.C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375 (1995) 291-298
32. Rodríguez-Roche R., Alvarez M., Holmes E.C., Bernardo L., Kouri G., Gould E.A., Halstead S., and Guzmán M.G. Dengue virus type 3, Cuba, 2000-2002. Emerg. Infect. Dis. 11 (2005) 773-774
33. Roehrig J.T. Antigenic structure of flavivirus proteins. Adv. Virus Res. 59 (2003) 141-175
34. Roehrig J.T., Bolin R.A., and Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the Dengue 2 Virus, Jamaica. Virology 246 (1998) 317-328
35. Rosario D., Álvarez A., Vázquez S., Amin N., Rodríguez R., Valdés K., and Guzmán M.G. Aplication of molecular methods to the diagnosis and characterization of a dengue outbreak in Cuba. Biotecnología Aplicada 18 (2001) 203-206
36. Sanger F., Niclen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5463-5467
37. Schlesinger J.J., Chapman S., Nestorowicz A., Rice C.M., Ginocchio T.E., and Chambers T.J. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and nonneuroadapted virus and partial sequence analysis of the neuroadapted strain. J. Gen. Virol. 77 (1996) 1277-1285
38. Silva, R., Selmán, M., Guillén, G., Herrera, L., Fernández, J.R., Novoa, L.I., Morales, J., Morera, V., González, S., Tamargo, B., del Valle, J., Caballero, E., Álvarez, A., Coizeau, E., Cruz, S., Musacchio, A., 1992. Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations, European Patent Application EP 0474313 A2.
39. Simmons M., Nelson W.M., Wu S.J., and Hayes C.G. Evaluation of the protective efficacy of a recombinant Dengue envelope B domain fusion protein against Dengue 2 virus infection in mice. Am. J. Trop. Med. Hyg. 58 (1998) 655-662
40. Srivastava A.K., Putnak R.J., Warren R.L., and Hoke C.H. Mice immunized with a Dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal Dengue virus infection. Vaccine 13 (1995) 1251-1258
41. Towbin H., Staehelin T., and Gordon H. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
42. Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8 (1990) 52-56
43. Willard L., Ranjan A., Zhang H., Monzavi H., Boyko R.F., Sykes B.D., and Wishart D.S. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res. 31 (2003) 3316-3319
44. Winkler G., Heinz F.X., and Kunz C. Characterization of a disulfide bridge-stabilized antigenic domain of tick-borne encephalitis virus structural glycoprotein. J. Gen. Virol. 68 (1987) 2239-2244
45. Zulueta A., Hermida L., Lazo L., Valdés I., Rodríguez R., López C., Silva R., Rosario D., Martín J., Guzmán M.G., and Guillén G. The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs. Biochem. Biophys. Res. Commun. 308 (2003) 619-626